ST PharmLtd Future Growth
Future criteria checks 5/6
ST PharmLtd is forecast to grow earnings and revenue by 40.1% and 20.3% per annum respectively. EPS is expected to grow by 39% per annum. Return on equity is forecast to be 12.9% in 3 years.
Key information
40.1%
Earnings growth rate
39.0%
EPS growth rate
Pharmaceuticals earnings growth | 33.1% |
Revenue growth rate | 20.3% |
Future return on equity | 12.9% |
Analyst coverage | Good |
Last updated | 04 Nov 2024 |
Recent future growth updates
Recent updates
ST Pharm Co.,Ltd.'s (KOSDAQ:237690) Shares Climb 29% But Its Business Is Yet to Catch Up
Aug 30Is Now The Time To Put ST PharmLtd (KOSDAQ:237690) On Your Watchlist?
Aug 17Is ST Pharm Co.,Ltd. (KOSDAQ:237690) Trading At A 41% Discount?
May 09Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem
Mar 22ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected
Mar 18Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%
Mar 16Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)
Jan 22What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?
Dec 23Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?
Nov 26Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 458,898 | 71,857 | 45,667 | 60,522 | 10 |
12/31/2025 | 368,288 | 54,200 | 25,833 | 52,089 | 10 |
12/31/2024 | 294,111 | 41,360 | 11,500 | 42,029 | 7 |
6/30/2024 | 272,887 | 21,706 | -23,243 | 22,468 | N/A |
3/31/2024 | 286,069 | 22,027 | -31,825 | 8,854 | N/A |
12/31/2023 | 284,992 | 19,581 | -42,145 | 1,298 | N/A |
9/30/2023 | 264,760 | 11,544 | -46,308 | 7,917 | N/A |
6/30/2023 | 269,638 | 17,810 | -37,321 | 24,400 | N/A |
3/31/2023 | 262,987 | 19,882 | -36,394 | 31,641 | N/A |
12/31/2022 | 249,322 | 18,000 | -53,339 | 7,031 | N/A |
9/30/2022 | 200,659 | 10,981 | -57,575 | 1,971 | N/A |
6/30/2022 | 186,130 | 8,285 | -50,022 | 6,557 | N/A |
3/31/2022 | 175,363 | 10,241 | -37,812 | 14,203 | N/A |
12/31/2021 | 165,642 | 3,312 | -44,648 | 7,270 | N/A |
9/30/2021 | 161,689 | 3,841 | -43,776 | 489 | N/A |
6/30/2021 | 137,778 | -10,640 | -35,930 | -4 | N/A |
3/31/2021 | 131,198 | -13,064 | -46,419 | -23,126 | N/A |
12/31/2020 | 124,109 | -12,147 | -38,379 | -20,935 | N/A |
9/30/2020 | 115,724 | -17,794 | -35,929 | -28,123 | N/A |
6/30/2020 | 113,385 | -11,788 | -39,485 | -31,636 | N/A |
3/31/2020 | 97,736 | -17,366 | -27,574 | -20,374 | N/A |
12/31/2019 | 93,257 | -18,529 | -36,608 | -30,517 | N/A |
9/30/2019 | 74,084 | -17,228 | -32,516 | -25,384 | N/A |
6/30/2019 | 67,420 | -22,920 | -37,753 | -22,816 | N/A |
3/31/2019 | 85,107 | -15,330 | -34,743 | -17,456 | N/A |
12/31/2018 | 97,738 | -9,268 | -16,545 | 10,767 | N/A |
9/30/2018 | 132,399 | 6,823 | -13,732 | 21,795 | N/A |
6/30/2018 | 162,380 | 21,376 | 3,610 | 37,041 | N/A |
3/31/2018 | 183,300 | 32,346 | N/A | 44,234 | N/A |
12/31/2017 | 202,800 | 44,997 | N/A | 54,437 | N/A |
9/30/2017 | 193,639 | 48,990 | N/A | 55,544 | N/A |
6/30/2017 | 204,253 | 57,391 | N/A | 63,059 | N/A |
3/31/2017 | 217,291 | 65,196 | N/A | 78,773 | N/A |
12/31/2016 | 200,362 | 61,426 | N/A | 50,778 | N/A |
9/30/2016 | 198,740 | 58,742 | N/A | 75,467 | N/A |
6/30/2016 | 190,495 | 54,579 | N/A | 65,683 | N/A |
12/31/2015 | 138,052 | 25,189 | N/A | 35,822 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A237690's forecast earnings growth (40.1% per year) is above the savings rate (2.7%).
Earnings vs Market: A237690's earnings (40.1% per year) are forecast to grow faster than the KR market (29% per year).
High Growth Earnings: A237690's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A237690's revenue (20.3% per year) is forecast to grow faster than the KR market (9.8% per year).
High Growth Revenue: A237690's revenue (20.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A237690's Return on Equity is forecast to be low in 3 years time (12.9%).